CLASS II Device recall · Reported 5 Sep 2018 · FDA Enforcement Report

Roche cobas p 612 pre-analytical system (63x) recalled

Roche Diagnostics is recalling Roche cobas p 612 pre-analytical system (63x), distributed in California, New York, Texas, Washington, Wisconsin. The recall was initiated on 16 Jul 2018 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAll units
Quantity recalled12 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2944-2018
FDA event ID
80617
Recalling firm
Roche Diagnostics, Indianapolis, IN
Classification
Class II
Status
Terminated
Recall initiated
16 Jul 2018
FDA classified
27 Aug 2018
Reported
5 Sep 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

16 Jul 2018Recall initiated by company
27 Aug 2018Classified by FDA+42 days
5 Sep 2018Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Sample material may potentially come in contact with the pipetting nozzle during operation of cobas p 612 pre-analytical system (63x) (LCP1) with non-filter tips. The possible presence of biological material on the nozzle may cause contamination resulting in potential false positive results, depending on the sensitivity of the analytical technology.

Product as listed by the FDA

Roche cobas p 612 pre-analytical system (63x) Model: 07563116001 The cobas p 612 pre-analytical system is a computer controlled fully automatic system for sorting of open and closed barcoded and centrifuged and non-centrifuged sample tubes. The cobas p 612 is intended for use with analyzers that perform tests in the area of clinical chemistry, immuno chemistry, coagulation, hematology, urinalysis, nucleic acid testing.

Where it was distributed

US Distribution to states of: CA, NY,TX, WA, and WI.

CaliforniaNew YorkTexasWashingtonWisconsin

Questions about this recall

Is Roche cobas p 612 pre-analytical system (63x) recalled?

Yes. Roche Diagnostics recalled Roche cobas p 612 pre-analytical system (63x) on 16 Jul 2018. The recall is Class II and its status is Terminated. Recall number Z-2944-2018.

Why was it recalled?

Sample material may potentially come in contact with the pipetting nozzle during operation of cobas p 612 pre-analytical system (63x) (LCP1) with non-filter tips. The possible presence of biological material on the nozzle may cause contamination resulting in potential false positive results, depending on the sensitivity of the analytical technology.

Which lots are affected?

All units

Where was it sold?

US Distribution to states of: CA, NY,TX, WA, and WI.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Roche Diagnostics

All 39

Other Test Kits & Diagnostics recalls

All 2,656